NCT00180843View on ClinicalTrials.gov

Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways Disease

NATerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

salbutamol + ipratropium bromide nebules

DRUG

nebulized saline

Trial Locations (1)

W12 0HS

Imperial College Hammersmith Campus, London

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Imperial College London

OTHER

NCT00180843 - Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways Disease | Biotech Hunter | Biotech Hunter